SHIGORAVAX

ShigOraVax is a collaborative project funded by the European & Developing Countries Clinical Trials Partnership (EDCTP2) Programme supported by the European Union. The project is the joint effort of leading Asian, African and European experts with proven track records in research and development of vaccines against poverty-related neglected diseases, including diarrhoeal diseases... The ShigOraVax project brings together a multidisciplinary consortium whose partners have complementary expertise in vaccine Research and Development (R&D) - from assay development, antigen discovery, over preclinical R&D and up to the early and mid-stage clinical testing of vaccine candidates in clinical trials - management, communication and innovation.

Primary location: Heidelberg Germany